Tuesday, January 20, 2026

CATEGORY

Healthcare Policy and Regulation

Indigenous Women’s Health: Overcoming Challenges in Prenatal and Postpartum Care

In a world where healthcare systems often overlook the needs of indigenous women, a new research study sheds light on the pressing issues and...

Community Attitudes Toward Cervical Screening in South India

In South India, cultural perceptions strongly influence health-seeking behaviors, particularly among women facing reproductive health issues. The dynamics of health decision-making often involve the...

Innovative Cancer Drug Toripalimab Undergoes Benefit Assessment in Germany

Nasopharyngeal carcinoma (NPC), a formidable oncological adversary, often proves challenging to treat, especially in cases that are recurrent or have metastasized. The emergence of...

Amyvid Scans: Enhancing Alzheimer’s Detection with Precision

A milestone in the realm of neurodegenerative disease diagnostics, Amyvid presents a seamless fusion of radiopharmaceutical innovation and clinical precision for Alzheimer's detection. By...

US Sees Significant Drop in Opioid Overdose Deaths as Fentanyl Influence Decreases

In a promising turn for public health, the United States witnessed a remarkable decline in opioid overdose deaths from mid-2023 to late 2024. A...

Germany Assigns Fixed Reimbursement Category to Ranolazine Tablets

Germany's Joint Federal Committee (G-BA) made a landmark decision on December 18, 2025, emphasizing the regulation of pharmaceutical pricing and reimbursement. The committee set...

Ozenoxacin: Regulatory Safety Update Report Highlights

Ozenoxacin, a widely used antibiotic, undergoes a critical safety evaluation within the European Union as part of a comprehensive regulatory process. As a systematic...

G-BA Raises Annual Therapy Costs for Mirikizumab in Crohn’s Disease Patients

A pivotal decision by Germany's Joint Federal Committee (G-BA) on January 13, 2026, revised the known annual therapy costs associated with Mirikizumab, particularly for...

Codeine and Paracetamol PSURs: EMA Evaluates New Safety Measures

The European Medicines Agency (EMA) initiated an evaluation of the safety of codeine and paracetamol drug combinations widely used across Europe. This effort aims...

Implementing an Enhanced Framework for Evaluating Symptom Checkers

Healthcare innovation witnesses a significant landmark with the introduction of a novel framework for evaluating digital symptom checkers. These applications, initially serving to aid...

Strengthening Health Services in Brazil: Bridging Surveillance and Primary Care Against Dengue

In an era marked by the rapid spread of infectious diseases, Brazil grapples with both enduring health issues and emerging threats. Dengue fever, exacerbated...

PDCO’s Strategic Movements in Paediatric Medicine Approvals

In November 2025, the Paediatric Committee (PDCO) convened to discuss the progress and status of various paediatric investigation plans and compliance checks, revealing a...

Radiologists Lead in Paracentesis and Thoracentesis in the U.S.

Radiologists have taken a prominent role in performing paracentesis and thoracentesis procedures, marking a significant trend over recent years. As traditional patterns of care...

NALIRIFOX Extends Survival More Than Standard Chemotherapy in Pancreatic Cancer

Pancreatic cancer remains one of the most challenging malignancies to treat due to its aggressive nature and limited response to conventional therapies. In a...

Influenza Vaccination as a Key Strategy to Mitigate Dementia Risk in Aging Populations

As global populations age, the quest to manage and diminish dementia risk becomes increasingly vital. While influenza vaccination is typically known for its role...

Latest news